Urethral cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(17 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Urethral cancer}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Urethral_cancer]]
{{CMG}};{{AE}}{{Vbe}}
{{CMG}}; {{AE}}{{MJ}}, {{Vbe}}


==Overview==
==Overview==
Line 7: Line 7:


==Differentiation==
==Differentiation==
[[Urethral cancer|Urethral]] [[cancer]] must be differentiated from the following diseases:
[[Urethral cancer|Urethral]] [[cancer]] must be differentiated from other diseases that cause lower [[urinary tract]] irritation symptoms (e.g., [[dysuria]], urgency and frequency in addition to urethral [[discharge]]); these include [[Bladder cancer]], [[Cervical cancer]], [[urethritis]], [[Bladder stones]], [[cystitis]], urethrolithiasis, [[Neurogenic bladder]], [[cervicitis]], [[vaginitis|vulvovaginitis]], and [[Epididymo-orchitis|epididymitis]]'''.'''<ref name=":0">{{Cite journal
* [[Bladder cancer]]<ref name="pmid23608423">{{cite journal |vauthors=Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R |title=Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study |journal=Urology |volume=81 |issue=5 |pages=1018–23 |date=May 2013 |pmid=23608423 |doi=10.1016/j.urology.2013.01.053 |url=}}</ref><ref name="pmid28140610">{{cite journal |vauthors=Kim TH, Kim SY, Moon KC, Lee J, Cho JY, Kim SH |title=Clear Cell Adenocarcinoma of the Urethra in Women: Distinctive MRI Findings for Differentiation From Nonadenocarcinoma and Non-Clear Cell Adenocarcinoma of the Urethra |journal=AJR Am J Roentgenol |volume=208 |issue=4 |pages=805–811 |date=April 2017 |pmid=28140610 |doi=10.2214/AJR.16.16929 |url=}}</ref>
* [[Cervical cancer]]
* [[Bladder stones]]
* Urethrolithiasis
* [[Cystitis]]
* [[Neurogenic bladder]]
* [[Urethritis]]
 
DDx for Urethritis:
 
Urethritis must be differentiated from other diseases that cause lower [[urinary tract]] irritation symptoms (e.g., [[dysuria]], urgency and frequency in addition to urethral [[discharge]]); these include '''[[cystitis]]''', '''[[cervicitis]]''', '''[[vaginitis|vulvovaginitis]]''', '''[[Epididymo-orchitis|epididymitis]]''', '''[[prostatitis]]''', and '''[[syphilis]]'''.<ref name=":0">{{Cite journal
  | author = [[Stephen Bent]], [[Brahmajee K. Nallamothu]], [[David L. Simel]], [[Stephan D. Fihn]] & [[Sanjay Saint]]
  | author = [[Stephen Bent]], [[Brahmajee K. Nallamothu]], [[David L. Simel]], [[Stephan D. Fihn]] & [[Sanjay Saint]]
  | title = Does this woman have an acute uncomplicated urinary tract infection?
  | title = Does this woman have an acute uncomplicated urinary tract infection?
Line 81: Line 70:
  | doi = 10.1007/s00345-005-0040-4
  | doi = 10.1007/s00345-005-0040-4
  | pmid = 16437219
  | pmid = 16437219
}}</ref>
}}</ref><ref name="pmid28140610">{{cite journal |vauthors=Kim TH, Kim SY, Moon KC, Lee J, Cho JY, Kim SH |title=Clear Cell Adenocarcinoma of the Urethra in Women: Distinctive MRI Findings for Differentiation From Nonadenocarcinoma and Non-Clear Cell Adenocarcinoma of the Urethra |journal=AJR Am J Roentgenol |volume=208 |issue=4 |pages=805–811 |date=April 2017 |pmid=28140610 |doi=10.2214/AJR.16.16929 |url=}}</ref><ref name="pmid23608423">{{cite journal |vauthors=Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R |title=Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study |journal=Urology |volume=81 |issue=5 |pages=1018–23 |date=May 2013 |pmid=23608423 |doi=10.1016/j.urology.2013.01.053 |url=}}</ref>
*The following table summarizes the differential diagnosis for urethritis.
*The following table summarizes the differential diagnosis for [[Urethral cancer|Urethral]] [[cancer]]:


{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
| colspan="5" |<small>'''Symptoms'''
| colspan="7" |<small>'''Symptoms'''
! colspan="4" |<small>Physical Examination</small>
! colspan="4" |<small>Physical Examination</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="1" rowspan="2" |<small>Past medical history</small>
! colspan="1" rowspan="2" |<small>Past medical history</small>
! rowspan="2" |<small>Other Findings</small>
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!<small>Hematuria</small>
!<small>Hematuria</small>
Line 98: Line 86:
!<small>Urgency</small>
!<small>Urgency</small>
!<small>Dysuria</small>
!<small>Dysuria</small>
!<small>Weak urine stream<small>
!<small>Mass<small>
!<small>Fever</small>
!<small>Fever</small>
!<small>Tenderness</small>
!<small>Tenderness</small>
Line 105: Line 95:
!<small>Urine Culture</small>
!<small>Urine Culture</small>
!<small>Gold Standard
!<small>Gold Standard
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Urethral Cancer
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |Malignant cells
RBC
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |Biopsy
| align="center" style="background:#F5F5F5;" + |
* Personal [[History and Physical examination|history]] of [[bladder cancer]].
* [[Conditions]] that cause [[chronic]] [[inflammation]] in the [[urethra]], including:
:* [[Sexually transmitted diseases]] (STDs), including [[human papillomavirus]] (especially HPV type 16)
:* Frequent [[urinary tract infections]] (UTIs)
:* White female
:* Age 60
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bladder cancer]]
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |Malignant cells
RBC
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |Biopsy
| align="center" style="background:#F5F5F5;" + |
* Smoking
* Occupational exposure to chemicals: Textiles, Rubber, Paint, Leather, Dye, Metal, Machining, Plastics, [[Arsenic]], Aristolochic acids
* Chronic bladder irritation
* Chronic [[urinary tract infection]]
* [[Bladder stones]]
* ''[[Schistosoma haematobium]]''
* Trauma
* [[Chemotherapy]]: [[Cyclophosphamide|yclophosphamide]], [[Ifosfamide]]
* [[Radiation therapy]]
* Personal history of cancer in the [[urinary tract]]
* [[Congenital]] bladder anomalies such as [[Urachus|rachus]], Exstrophy
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cervical cancer]]
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |Biopsy
| align="center" style="background:#F5F5F5;" + |
*'''Specific risk factor: Human papillomavirus (HPV) infection''':<ref>[http://www.cancer.org/docroot/CRI/content/CRI_2_2_2X_What_causes_cancer_of_the_cervix_Can_it_be_prevented_8.asp?sitearea=]  American Cancer Society</ref><ref>[http://www.mdlab.com/html/testing/hpv_typedetect.html]</ref><ref>[http://www.cancer.gov/newscenter/benchmarks-vol2-issue4/page2]</ref><ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>
*Other risk factors for cervical cancer include the following: <ref name="pmid30212064">{{cite journal |vauthors=Kim JJ, Burger EA, Regan C, Sy S |title= |journal= |volume= |issue= |pages= |date= |pmid=30212064 |doi= |url=}}</ref><ref name="pmid30172799">{{cite journal |vauthors=Tatar O, Thompson E, Naz A, Perez S, Shapiro GK, Wade K, Zimet G, Gilca V, Janda M, Kahn J, Daley E, Rosberger Z |title=Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis |journal=Prev Med |volume=116 |issue= |pages=40–50 |date=November 2018 |pmid=30172799 |doi=10.1016/j.ypmed.2018.08.034 |url=}}</ref>
::*'''Smoking'''
::*'''HIV infection'''
::*'''Increased number of sexual partners'''
::*'''Young age at time of first sexual intercourse'''
::*'''Hormonal contraception'''
::*'''High parity''' '''DES (diethylstilbestrol)''':
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bladder stones]]
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |RBC
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |CT scan without contrast
| align="center" style="background:#F5F5F5;" + |
Common risk factors in the development of nephrolithiasis include:
* Dietary habits
* Low urinary pH
* [[Hypercalcemia]]
* [[Hypercalciuria]]
* [[Hyperoxaluria]]
* [[Hyperuricemia]]
* [[Hyperuricosuria]]
* [[Metabolic syndrome]]
* [[Obesity]]
* [[Diabetes mellitus]]
* Environmental - such as hot climate
* Drugs
** [[Thiazide]]
** [[Furosemide]]
** [[Sulfadiazine]]
** [[Indinavir]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Ureterolithiasis
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |RBC
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |CT scan without contrast
| align="center" style="background:#F5F5F5;" + |Same as bladder cancer
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurogenic bladder]]
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |Urodynamic study (UDS)
| align="center" style="background:#F5F5F5;" + |
* Spinal cord diseases, injuries
* Neural tube defects including [[spina bifida]].
* [[Brain tumor]]s
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urethritis|'''Urethritis''']]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urethritis|'''Urethritis''']]
Line 112: Line 260:
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
Line 127: Line 277:
* Recent intercourse
* Recent intercourse
* Recent [[catheterization]]
* Recent [[catheterization]]
| align="left" style="background:#F5F5F5;" + |
*[[Purulent]] [[discharge]] may suggest [[gonorrhoea]]
*Exclusive [[dysuria]] suggest [[Chlamydia]]
*Painful genital [[ulcers]] with [[dysuria]] suggest [[HSV]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyelonephritis|'''Pyelonephritis''']]
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |  +
| align="center" style="background:#F5F5F5;" + | [[Flank pain|Flank]] or [[costovertebral angle]]
| align="center" style="background:#F5F5F5;" + |  +
| align="center" style="background:#F5F5F5;" + |  +
| align="left" style="background:#F5F5F5;" + |
*[[Leukocytes]]
*[[Nitrite test|Nitrite]] +ve
| align="center" style="background:#F5F5F5;" + | Identifies causative [[bacteria]]
| align="center" style="background:#F5F5F5;" + | [[Urine culture]]
| align="left" style="background:#F5F5F5;" + |
* History of [[pyelonephritis]]
* Recent history of [[hospitalisation]]
* [[Nephrolithiasis]]
* [[Immunosupression]]
| align="left" style="background:#F5F5F5;" + |
* [[Flank pain|Costovertebral angle tenderness]]
* Patient is in acute distress
* Look for obstructive causes
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Cystitis|'''Cystitis''']]
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Cystitis|'''Cystitis''']]
Line 163: Line 284:
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |  +
| align="center" style="background:#F5F5F5;" + |  +
| align="center" style="background:#F5F5F5;" + | Suprapubic
| align="center" style="background:#F5F5F5;" + | Suprapubic
Line 183: Line 306:
*[[BPH]]
*[[BPH]]
*[[HIV]]
*[[HIV]]
| align="left" style="background:#F5F5F5;" + |
* Imaging studies help differentiate the various types
* May accompany [[back pain]], [[nausea]], [[vomiting]], and [[chills]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis|'''Prostatitis''']]
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="left" style="background:#F5F5F5;" + |
*10–20 [[leukocytes]] for acute and chronic [[bacterial]] subtypes
| align="center" style="background:#F5F5F5;" + | Identifies causative [[bacteria]] (in [[bacterial]] subtypes)
| align="center" style="background:#F5F5F5;" + | [[Urine culture]]
| align="left" style="background:#F5F5F5;" + |
* [[Urogenital]] disorders
* Recent [[catheterization]] or other [[genitourinary]] instrumentation
* History of [[UTI|UTIs]]
| align="left" style="background:#F5F5F5;" + |
*[[Tenderness|Tender]] and [[enlarged prostate]] in [[acute prostatitis]]<sup>[[Prostatitis physical examination|[1][3]]]</sup>
*Tender and soft (boggy) [[prostate]] in chronic [[prostatitis]]<sup>[[Prostatitis physical examination|[1]]]</sup>
* A [[prostate massage]] should never be done in a patient with suspected [[acute prostatitis]], since it may induce [[sepsis]].
|-
|-
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
| colspan="5" |<small>'''Symptoms'''
| colspan="7" |<small>'''Symptoms'''
! colspan="4" |<small>Physical Examination</small>
! colspan="4" |<small>Physical Examination</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="1" rowspan="2" |<small>Past medical history</small>
! colspan="1" rowspan="2" |<small>Past medical history</small>
! rowspan="2" |<small>Other Findings</small>
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!<small>Hematuria</small>
!<small>Hematuria</small>
Line 223: Line 319:
!<small>Urgency</small>
!<small>Urgency</small>
!<small>Dysuria</small>
!<small>Dysuria</small>
!<small>Weak urine stream
!<small>Mass<small>
!<small>Fever</small>
!<small>Fever</small>
!<small>Tenderness</small>
!<small>Tenderness</small>
Line 237: Line 335:
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + |–
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
Line 248: Line 348:
* Prior [[STDs]]
* Prior [[STDs]]
* Previous history of symptomatic BV in female partner (in [[homosexual]] women)
* Previous history of symptomatic BV in female partner (in [[homosexual]] women)
| align="left" style="background:#F5F5F5;" + |
* Fishy [[odor]] from the [[vagina]] (Whiff test)
* Thin, white/gray homogeneous [[vaginal discharge]]
* [[Microscopy]] (wet prep) and vaginal [[pH]] 
* Clue cells
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Cervicitis|'''Cervicitis''']]
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Cervicitis|'''Cervicitis''']]
Line 260: Line 355:
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | Cervical
| align="center" style="background:#F5F5F5;" + | Cervical
Line 272: Line 369:
* Painful sexual intercourse
* Painful sexual intercourse
* Pressure or heaviness in the [[pelvis]]
* Pressure or heaviness in the [[pelvis]]
| align="left" style="background:#F5F5F5;" + |
*[[Purulent]] or [[mucopurulent]] endocervical exudate
*Sustained endocervical [[bleeding]] easily induced by a cotton swab
*>10 [[WBC]] in vaginal fluid, in the absence of [[trichomoniasis]], may indicate endocervical [[inflammation]] caused specifically by ''[[C. trachomatis]]'' or ''[[N. gonorrhea]]''
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Epididymitis|'''Epididymitis''']]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Epididymitis|'''Epididymitis''']]
Line 283: Line 376:
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + | +  
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | [[Testicular]] & suprapubic
| align="center" style="background:#F5F5F5;" + | [[Testicular]] & suprapubic
Line 296: Line 391:
*[[Scrotum|Scrotal]] wall [[erythema]]
*[[Scrotum|Scrotal]] wall [[erythema]]
*Constitutional symptoms: feeling warm, [[chills]], [[nausea and vomiting]]
*Constitutional symptoms: feeling warm, [[chills]], [[nausea and vomiting]]
| align="left" style="background:#F5F5F5;" + |
*[[Ultrasound]] in patients with [[Testicular pain|acute testicular pain]] to assess for [[testicular torsion]]
*If equivocal do surgical exploration
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Syphilis]]'''
'''([[STDs|STD]])'''
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | +/–
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | –
| align="center" style="background:#F5F5F5;" + | [[Dark field microscopy|Darkfield microscopy]]
| align="left" style="background:#F5F5F5;" + |
* History of [[STD]]
* [[HIV AIDS|HIV]]
* [[Immunosupression]]
* Previous history of [[chancre]]
| align="left" style="background:#F5F5F5;" + |
* May be asymptomatic
* Painless [[chancre]] in [[primary syphilis]]
* [[Secondary syphilis]] may have generalised features and condylomata lata
* [[Tertiary syphilis]] can have [[neurosyphilis]], [[cardiovascular syphilis]] and gummas
|-
|-
|}
|}

Latest revision as of 21:28, 14 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [5]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [6], Vindhya BellamKonda, M.B.B.S [7]

Overview

Urethral cancer must be differentiated from bladder cancer, cervical cancer, bladder stones, ureteral stones, cystitis, neurogenic bladder, and urethritis.

Differentiation

Urethral cancer must be differentiated from other diseases that cause lower urinary tract irritation symptoms (e.g., dysuria, urgency and frequency in addition to urethral discharge); these include Bladder cancer, Cervical cancer, urethritis, Bladder stones, cystitis, urethrolithiasis, Neurogenic bladder, cervicitis, vulvovaginitis, and epididymitis.[1][2][3][4][5][6][7][8][9][10][11]

  • The following table summarizes the differential diagnosis for Urethral cancer:
Diseases Symptoms Physical Examination Diagnostic tests Past medical history
Hematuria Pyuria Frequency Urgency Dysuria Weak urine stream Mass Fever Tenderness Discharge Inguinal Lymphadenopathy Urinalysis Urine Culture Gold Standard
Urethral Cancer + +/– +/– +/– + + Malignant cells

RBC

Biopsy
Bladder cancer + +/– +/– +/– Malignant cells

RBC

Biopsy
Cervical cancer +/– +/– +/– Biopsy
  • Other risk factors for cervical cancer include the following: [16][17]
  • Smoking
  • HIV infection
  • Increased number of sexual partners
  • Young age at time of first sexual intercourse
  • Hormonal contraception
  • High parity DES (diethylstilbestrol):
Bladder stones + + +/– +/– RBC CT scan without contrast

Common risk factors in the development of nephrolithiasis include:

Ureterolithiasis + + + +/– RBC CT scan without contrast Same as bladder cancer
Neurogenic bladder +/– +/– Urodynamic study (UDS)
Urethritis + + +/– + Urethral discharge + Gram stain & mucoid or purulent discharge
Cystitis + + + + + + Suprapubic + >100,000CFU/mL Urine culture
Diseases Symptoms Physical Examination Diagnostic tests Past medical history
Hematuria Pyuria Frequency Urgency Dysuria Weak urine stream Mass Fever Tenderness Discharge Inguinal Lymphadenopathy Urinalysis Urine Culture Gold Standard
Vulvovagintis + + Vaginal discharge  + Gram stain & culture of discharge
  • Number and type of sexual partners (new, casual, or regular)
  • Prior STDs
  • Previous history of symptomatic BV in female partner (in homosexual women)
Cervicitis + + + Cervical Endocervical exudate Culture for gonococcal cervicitis
Epididymitis + + + + + Testicular & suprapubic +/– urethral discharge + + Culture

References

  1. Stephen Bent, Brahmajee K. Nallamothu, David L. Simel, Stephan D. Fihn & Sanjay Saint (2002). "Does this woman have an acute uncomplicated urinary tract infection?". JAMA. 287 (20): 2701–2710. PMID 12020306. Unknown parameter |month= ignored (help)
  2. W. E. Stamm (1981). "Etiology and management of the acute urethral syndrome". Sexually transmitted diseases. 8 (3): 235–238. PMID 7292216. Unknown parameter |month= ignored (help)
  3. W. E. Stamm, K. F. Wagner, R. Amsel, E. R. Alexander, M. Turck, G. W. Counts & K. K. Holmes (1980). "Causes of the acute urethral syndrome in women". The New England journal of medicine. 303 (8): 409–415. doi:10.1056/NEJM198008213030801. PMID 6993946. Unknown parameter |month= ignored (help)
  4. Leonie G. M. Giesen, Grainne Cousins, Borislav D. Dimitrov, Floris A. van de Laar & Tom Fahey (2010). "Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs". BMC family practice. 11: 78. doi:10.1186/1471-2296-11-78. PMID 20969801.
  5. Taylor-Robinson D (1996). "The history of nongonococcal urethritis. Thomas Parran Award Lecture". Sex Transm Dis. 23 (1): 86–91. PMID 8801649.
  6. Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
  7. Brill JR (2010). "Diagnosis and treatment of urethritis in men". Am Fam Physician. 81 (7): 873–8. PMID 20353145.
  8. Daniel V. Landers, Harold C. Wiesenfeld, R. Phillip Heine, Marijane A. Krohn & Sharon L. Hillier (2004). "Predictive value of the clinical diagnosis of lower genital tract infection in women". American journal of obstetrics and gynecology. 190 (4): 1004–1010. doi:10.1016/j.ajog.2004.02.015. PMID 15118630. Unknown parameter |month= ignored (help)
  9. Felix Millan-Rodriguez, J. Palou, Anna Bujons-Tur, Mireia Musquera-Felip, Carlota Sevilla-Cecilia, Marc Serrallach-Orejas, Carlos Baez-Angles & Humberto Villavicencio-Mavrich (2006). "Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract". World journal of urology. 24 (1): 45–50. doi:10.1007/s00345-005-0040-4. PMID 16437219. Unknown parameter |month= ignored (help)
  10. Kim TH, Kim SY, Moon KC, Lee J, Cho JY, Kim SH (April 2017). "Clear Cell Adenocarcinoma of the Urethra in Women: Distinctive MRI Findings for Differentiation From Nonadenocarcinoma and Non-Clear Cell Adenocarcinoma of the Urethra". AJR Am J Roentgenol. 208 (4): 805–811. doi:10.2214/AJR.16.16929. PMID 28140610.
  11. Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R (May 2013). "Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study". Urology. 81 (5): 1018–23. doi:10.1016/j.urology.2013.01.053. PMID 23608423.
  12. [1] American Cancer Society
  13. [2]
  14. [3]
  15. [4]
  16. Kim JJ, Burger EA, Regan C, Sy S. PMID 30212064. Missing or empty |title= (help)
  17. Tatar O, Thompson E, Naz A, Perez S, Shapiro GK, Wade K, Zimet G, Gilca V, Janda M, Kahn J, Daley E, Rosberger Z (November 2018). "Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis". Prev Med. 116: 40–50. doi:10.1016/j.ypmed.2018.08.034. PMID 30172799.